Paul Bisaro files SEC Form 4 disclosures for BARR PHARMACEUTICALS INC. They have made 36 open-market trades across 8 companies since 2006, most recently 2026-06-04.
CIK 0001237253
7 open-market purchases totalling $876K since 2015, against 29 sales. Across 7 scored buys the stock is down 23.8% at ninety days, and 28.6 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 57% | 71% | 29% |
| Avg Move | +0.2% | -0.9% | -23.8% |
| Alpha | +0.6% | -2.3% | -28.6% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MYGN | BUY | 2026-05-14 | 2026-05-14 | $3.69 | $28K | +5.8% | +15.9% | -13.0% |
| ZTS | BUY | 2026-05-13 | 2026-05-13 | $75.88 | $152K | +7.5% | +6.6% | +1.0% |
| MNK | BUY | 2023-03-14 | 2023-03-16 | $8.47 | $42K | -5.3% | -35.3% | -84.7% |
| TXMD | BUY | 2021-08-16 | 2021-08-18 | $0.79 | $40K | +8.3% | -6.1% | -20.5% |
| TXMD | BUY | 2020-06-04 | 2020-06-08 | $1.14 | $114K | -18.9% | +6.8% | -10.1% |
| AMRX | BUY | 2019-03-12 | 2019-03-12 | $11.97 | $203K | +10.5% | +5.5% | -39.5% |
| AGN | SELL | 2017-03-02 | 2017-03-06 | $246.68 | $17.3M | -0.2% | -0.9% | -4.9% |
| AGN | SELL | 2017-03-02 | 2017-03-06 | $246.68 | $17.3M | -0.2% | -0.9% | -4.9% |
| AGN | BUY | 2015-08-24 | 2015-08-24 | $297.42 | $297K | -6.3% | +0.3% | +0.3% |
| ACT | SELL | 2013-11-11 | 2013-11-13 | $158.73 | $6.5M | +0.0% | +0.0% | +0.0% |
| ACT | SELL | 2013-08-20 | 2013-08-22 | $135.30 | $6.8M | +0.0% | +0.0% | +0.0% |
| BRL | SELL | 2007-10-22 | 2007-10-24 | $54.07 | $811K | N/A | N/A | N/A |
| BRL | SELL | 2007-10-19 | 2007-10-22 | $54.28 | $543K | N/A | N/A | N/A |
| BRL | SELL | 2007-10-18 | 2007-10-19 | $54.70 | $547K | N/A | N/A | N/A |
| BRL | SELL | 2007-10-16 | 2007-10-18 | $55.30 | $852K | N/A | N/A | N/A |
| BRL | SELL | 2007-10-11 | 2007-10-12 | $55.75 | $558K | N/A | N/A | N/A |
| BRL | SELL | 2007-10-10 | 2007-10-11 | $55.61 | $556K | N/A | N/A | N/A |
| BRL | SELL | 2007-10-09 | 2007-10-10 | $55.78 | $558K | N/A | N/A | N/A |
| BRL | SELL | 2007-10-05 | 2007-10-09 | $56.00 | $403K | N/A | N/A | N/A |
| BRL | SELL | 2007-10-01 | 2007-10-03 | $57.02 | $3.4M | N/A | N/A | N/A |
| BRL | SELL | 2007-09-27 | 2007-10-01 | $56.08 | $1.1M | N/A | N/A | N/A |
| BRL | SELL | 2007-09-26 | 2007-09-27 | $55.86 | $1.4M | N/A | N/A | N/A |
| BRL | SELL | 2007-09-24 | 2007-09-25 | $54.26 | $2.4M | N/A | N/A | N/A |
| BRL | SELL | 2007-09-20 | 2007-09-24 | $53.57 | $1.1M | N/A | N/A | N/A |
| BRL | SELL | 2007-09-19 | 2007-09-20 | $53.10 | $531K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| PrivateUnlisted |
| 6,244 |
| — |
| BRL | 133,078 | — |
| WPI | 307,339 | — |
| Total | $74.1M |
Shares reported on the most recent Form 4, priced at the 2026-06-05 close. 3 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.